fbpx
Peter Werner Hansen

Peter Werner Hansen – Partner and Project Director

As Project Manager Peter’s primary responsibility is to execute the projects, “and make sure we are getting somewhere” as he says. He is an expert in materialising products and product development processes, with a broad experience in project and team management. Peter has helped bring more than 200 products to the market. Internally, he is […]

Read More
Kasper Friis

Kasper Friis – Partner and Head of UX and Design

Kasper is responsible for user experience and design and that the products Technolution develops, meet users’ needs throughout the user interaction and across platforms, both physically and digitally. Interaction design is not just about user efficiency, but also to make sure the product actually brings new value into the users’ lives – in all situations. […]

Read More
Shareholders

Technolution has made employees co-owners to ensure future growth

Technolution A/S is an engineering company that offers consultancy and innovation to the medical industry. The management has now decided to offer all employees co-ownership. The purpose is to develop, maintain and attract the much sought after medico skills that are crucial to the company’s future development. Health technology has a high growth potential. Technolution […]

Read More
Morten Bæk Nielsen

Welcome to Morten

Morten is a newly graduated engineer M.Sc. from DTU, where he made his thesis on robust design. The thesis was conducted in cooperation with Radiometer and aimed at developing a tool that gather and present information on robustness for a product. Morten has previously worked as an intern at LEGO, where he was part of […]

Read More
FDA AI requests

New forces in regulatory affairs eases the approval process for medical devices

As shown in the graph above, only 31% of all 510(k) applications (Premarket Notifications) goes through the approval process without a request for ‘Additional Information’ (AI) from the US approval authority; U. S. Food and Drug Administration (FDA). This figure clarifies and emphasizes the bureaucratic and often confusing approval process that all medical devices must […]

Read More

Four reasons why you should communicate more visually

We have all had them in our hands. Long reports and internal documents stuffed with stock phrases, numbers, percentages, lines of reasoning and disclaimers. Documents that tempts us to only skim the executive summary because reading the whole thing will occupy us for several hours, and because we know that we will not even be […]

Read More
Marianne Lind

Welcome Marianne

Marianne is an expert in quality systems – ISO9001, AS9100, the Medical Device Standard ISO13485, including the Special Design Control Process in Medical Device Development and has worked with quality systems in the last 15 years. Most recently for 10 years at Coloplast. Marianne has also worked extensively with validation – processes, clean rooms and […]

Read More
3D printer

Welcome to the new member of our family

FORMLABS FORM 2 Throughout the years, people have often asked us why we do not own a 3D printer, presumably because these are marketed as an essential tool in product development. The truth is that we have been using 3D printed prototypes throughout the last decade, but having a printer at the office has never […]

Read More
Why the fail fast mantra will kill your business

Why the ‘Fail Fast’ mantra will kill you business

The design community has fully adopted Design Thinking as a tool for conducting rapid and efficient product innovation. At the heart of this lies the chief mantra “Fail fast, fail cheap, and fail early”, which is commonly used throughout the larger worlds of innovation and entrepreneurship. Unfortunately for businesses and entrepreneurs alike, embracing this mantra […]

Read More
Dollars

”A day sooner is worth a million dollars”

THE IMPACTS OF A HIGH-SPEED PROJECT History has shown that reduced time-to-market has a huge impact on revenue. The expression “a day sooner is worth a million dollars” originates from the pharma industry and saw the light of day in the mid 1990’s. One of the most effective ways of reducing time-to-market is by embracing […]

Read More